Table 1.
5-year follow-up (n=41) |
8-year follow-up* (n=12) |
|
---|---|---|
Gender distribution | 27 men, 14 women | 8 men, 4 women |
Age at onset (mean±SD, years) | 43.3±9.8 | 40.4±9.8 |
Age at surgery (mean±SD, years) | 56.2±8.4 | 52.8±10.1 |
Disease duration (mean±SD years) | 12.9±5.8 | 12.3±4 |
L-dopa equivalent dose (LED) | 1471±515 | 1475±525 |
*Baseline features between the total cohort and the patients followed beyond 8 years did not differ significantly.